Research Article

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes

Table 1

Clinical characteristics of patients and controls without diabetes.

Clinical characteristicsHNF1AGCKT1DMT2DMControls value

Gender F (%)26 (36.1)29 (40.3)21 (55.7)39 (55.7)23 (35.4)0.0990
Age at the examination (years)40.28 ± 14.7736.83 ± 14.6531.72 ± 11.7158.96 ± 10.2538.02 ± 11.70<0.0001
Age at diagnosis (years)24.95 ± 10.9626.19 ± 13.0918.58 ± 10.9752.16 ± 10.34<0.0001
Diabetes duration (years)16.7 ± 11.0210.58 ± 8.1512.81 ± 9.456.8 ± 6.41<0.0001
Body mass index (kg/m2)24.05 ± 4.0023.64 ± 4.4024.43 ± 3.2030.48 ± 4.7623.91 ± 2.93<0.0001
Fasting glucose (mmol/L)6.91 ± 2.686.82 ± 1.217.92 ± 3.187.52 ± 1.945.12 ± 0.53<0.0001
HbA1c (%)6.83 ± 1.416.33 ± 0.677.41 ± 1.307.04 ± 1.33<0.0001
C-peptide (ng/mL)1.33 ± 0.661.31 ± 0.980.20 ± 0.252.41 ± 1.231.55 ± 0.66<0.0001
Total cholesterol (mmol/L)4.79 ± 0.975.05 ± 1.094.41 ± 0.764.61 ± 0.975.04 ± 0.810.0005
LDL-C (mmol/L)2.64 ± 0.862.97 ± 0.852.44 ± 0.722.56 ± 0.843.04 ± 0.76<0.0001
HDL-C (mmol/L)1.59 ± 0.421.62 ± 0.421.63 ± 0.431.23 ± 0.371.53 ± 0.41<0.0001
Triglycerides (mmol/L)1.23 ± 0.920.93 ± 0.360.85 ± 0.361.82 ± 1.021.01 ± 0.49<0.0001
Creatinine (mmol/L)70.39 ± 15.2670.46 ± 14.3368.63 ± 14.7775.34 ± 17.6174.4 ± 13.120.0646
CRP (mg/L)0.71 ± 1.161.69 ± 2.851.53 ± 1.473.2 ± 5.060.95 ± 0.89<0.0001
Cystatin C (mg/L)0.75 ± 0.210.72 ± 0.160.87 ± 0.150.9 ± 0.230.70 ± 0.13<0.0001
Urine albumin/creatine ratio (μg/mg)6.38 ± 29.622.72 ± 13.063.66 ± 9.277.38 ± 17.850.0439
eGFR-cys (mL/min/1.73 m2)110.94 ± 21.57113.73 ± 18.49100.02 ± 17.5589.64 ± 21.64116.24 ± 15.56<0.0001
eGFR-cr (mL/min/1.73 m2)102.86 ± 19.32105.14 ± 18.13111.48 ± 15.888.66 ± 16.9999.45 ± 14.35<0.0001
eGRF-cys - eGFR-cr (ml/min/1.73 m2)−8.9 ± 18.7−9.7 ± 17.011.6 ± 21.2−1.00 ± 16.3−16.9 ± 15.0<0.0001

Data are presented as mean and standard deviation (SD). For categorical variable numbers and percentage were used.
value derived from one-way analysis of variance (ANOVA) or Kruskal-Wallis test to detect a significant difference in the variable levels among study groups.